Castle Biosciences, Inc. provided revenue guidance for the full year 2022. The company anticipated generating between $115-120 million in total revenue in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.55 USD | +0.32% | +6.61% | -14.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.04% | 512M | |
-4.72% | 12.35B | |
+99.06% | 8.55B | |
-22.10% | 6.6B | |
+8.48% | 5.88B | |
-22.96% | 3.52B | |
+6.08% | 2.55B | |
+38.04% | 2.39B | |
-7.04% | 2.33B | |
-68.75% | 2.09B |
- Stock Market
- Equities
- CSTL Stock
- News Castle Biosciences, Inc.
- Castle Biosciences, Inc. Provides Revenue Guidance for the Full Year 2022